Paul G Ambrose (P G Ambrose)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Escherichia Coli

Urinary Tract Infection

Emergency Department

Molecularly Imprinted

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander J Lepak, Brian D VanScoy, Christopher M Rubino, Paul G Ambrose, David R Andes
In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Alexander J Lepak, Brian D VanScoy, Christopher M Rubino, Paul G Ambrose, David R Andes
In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model. Antimicrobial agents and chemotherapy (2024)
Alexander J Lepak, Brian D VanScoy, Christopher M Rubino, Paul G Ambrose, David R Andes
In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Alexander J Lepak, Brian D VanScoy, Christopher M Rubino, Paul G Ambrose, David R Andes
In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Alexander J Lepak, Brian D VanScoy, Christopher M Rubino, Paul G Ambrose, David R Andes
In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, Kathryn Liolios, Michael Trang, Christopher M Rubino, Judith N Steenbergen, Lawrence Friedrich, Evan Tzanis, Paul G Ambrose
Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections. Antimicrobial agents and chemotherapy (2024)
Alexander J Lepak, Brian D VanScoy, Christopher M Rubino, Paul G Ambrose, David R Andes
In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Brian D VanScoy, S Jones, H Conde, L V Friedrich, Nicole Cotroneo, Sujata M Bhavnani, Paul G Ambrose
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model. Antimicrobial agents and chemotherapy 67 (3) (2023)
Brian D VanScoy, S Jones, H Conde, L V Friedrich, Nicole Cotroneo, Sujata M Bhavnani, Paul G Ambrose
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model. Antimicrobial agents and chemotherapy 67 (3) (2023)
Brian D VanScoy, S Jones, H Conde, L V Friedrich, Nicole Cotroneo, Sujata M Bhavnani, Paul G Ambrose
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model. Antimicrobial agents and chemotherapy 67 (3) (2023)
A J Lepak, Michael Trang, J P Hammel, Helio Silva Sader, Sujata M Bhavnani, Brian D VanScoy, J M Pogue, Paul G Ambrose, David R Andes, null null
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches. Antimicrobial agents and chemotherapy (2023)
Brian D VanScoy, S Jones, H Conde, L V Friedrich, Nicole Cotroneo, Sujata M Bhavnani, Paul G Ambrose
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model. Antimicrobial agents and chemotherapy (2023)
Brian D VanScoy, S Jones, H Conde, L V Friedrich, Nicole Cotroneo, Sujata M Bhavnani, Paul G Ambrose
Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model. Antimicrobial agents and chemotherapy 67 (3) (2023)
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, Michael Trang, Justin C Bader, Catharine C Bulik, Brian D VanScoy, Christopher M Rubino, Michael D Huband, Lawrence Friedrich, Judith N Steenbergen, Paul G Ambrose
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae. Antimicrobial agents and chemotherapy (2023)
Sujata M Bhavnani, Michael Trang, David C Griffith, Olga Lomovskaya, J P Hammel, J S Loutit, S K Cammarata, M N Dudley, Paul G Ambrose, Christopher M Rubino
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints. Antimicrobial agents and chemotherapy (2022)
Brian D VanScoy, Elizabeth A Lakota, Haley Conde, Steven Fikes, Sujata M Bhavnani, Philippa B Elefante, Nicole E Scangarella-Oman, Paul G Ambrose
Gepotidacin Pharmacokinetics-Pharmacodynamics against Escherichia coli in the One-Compartment and Hollow-Fiber In Vitro Infection Model Systems. Antimicrobial agents and chemotherapy 65 (12) (2021)